COXSACKIE A ANTIBODY PANEL Test
Test Name: COXSACKIE A ANTIBODY PANEL Test
Components: Includes Antibodies A2, A4, A7, A9, A10 & A16
Price: 2220.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Duly filled Test Send Out Consent Fornis mandatory.
Report Delivery: Sample by 7th of the month; Report after 2-3 weeks
Method: Complement Fixation
Test type: Infections
Doctor: Physician
Test Department: OS
Pre Test Information: Duly filled Test Send Out Consent Fornis mandatory.
What is the COXSACKIE A ANTIBODY PANEL Test?
The COXSACKIE A antibody panel test is a blood test used to detect the presence of antibodies against Coxsackie A viruses. Coxsackie A viruses belong to a group of viruses called enteroviruses, which can cause various illnesses including hand, foot, and mouth disease, as well as viral meningitis.
The antibody panel test measures the levels of specific antibodies produced by the immune system in response to Coxsackie A virus infection. It can help diagnose a current or past infection with Coxsackie A viruses, as well as determine immunity to these viruses.
How is the Test Conducted?
The test involves taking a blood sample from a vein, usually in the arm. The sample is then sent to a laboratory for analysis.
Interpreting the Test Results
Results of the test can indicate the presence of IgM antibodies, which typically indicate a recent or active infection, or IgG antibodies, which usually suggest a past infection or immunity.
The COXSACKIE A antibody panel test can be useful in diagnosing Coxsackie A virus infections, especially in cases where symptoms are not clear or when a more definitive diagnosis is needed. It can also be used to monitor the effectiveness of treatment or to determine if an individual has developed immunity to Coxsackie A viruses.
It is important to note that the COXSACKIE A antibody panel test should be interpreted in conjunction with clinical symptoms and other diagnostic tests to make an accurate diagnosis. It is recommended to consult with a healthcare provider for further evaluation and interpretation of test results.
| Test Name | COXSACKIE A ANTIBODY PANEL Test |
|---|---|
| Components | Includes Antibodies A2, A4, A7, A9, A10 & A16 |
| Price | 2220.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Duly filled Test Send Out Consent Fornis mandatory. |
| Report Delivery | Sample by 7th of the month; Report after 2??3 weeks |
| Method | Complement Fixation |
| Test type | Infections |
| Doctor | Physician |
| Test Department: | OS |
| Pre Test Information | Duly filled Test Send Out Consent Fornis mandatory. |
| Test Details | The COXSACKIE A antibody panel test is a blood test used to detect the presence of antibodies against Coxsackie A viruses. Coxsackie A viruses belong to a group of viruses called enteroviruses, which can cause various illnesses including hand, foot, and mouth disease, as well as viral meningitis. The antibody panel test measures the levels of specific antibodies produced by the immune system in response to Coxsackie A virus infection. It can help diagnose a current or past infection with Coxsackie A viruses, as well as determine immunity to these viruses. The test involves taking a blood sample from a vein, usually in the arm. The sample is then sent to a laboratory for analysis. Results of the test can indicate the presence of IgM antibodies, which typically indicate a recent or active infection, or IgG antibodies, which usually suggest a past infection or immunity. The COXSACKIE A antibody panel test can be useful in diagnosing Coxsackie A virus infections, especially in cases where symptoms are not clear or when a more definitive diagnosis is needed. It can also be used to monitor the effectiveness of treatment or to determine if an individual has developed immunity to Coxsackie A viruses. It is important to note that the COXSACKIE A antibody panel test should be interpreted in conjunction with clinical symptoms and other diagnostic tests to make an accurate diagnosis. It is recommended to consult with a healthcare provider for further evaluation and interpretation of test results. |
